{"title":"癌症犬类嗜神经病毒疫苗（CIMT-54）的免疫治疗","authors":"Puello Hugo Ramiro Segurab, Charry Juan Sebastián Segura, Muñoz-Forero Diana Milena, Mosquera Diana Lorena Nieto, Villamil-Ballesteros Andrea Catalina","doi":"10.23937/2643-4563/1710018","DOIUrl":null,"url":null,"abstract":"• Page 1 of 8 • Citation: Segura-Puello HR, Charry JSS, Muñoz-Forero DM, Mosquera DJN, Villamil-Ballesteros AC (2019) Immunotherapy with the Vaccine Based On the Canine Neurotropic Virus (CIMT-54) For the Treatment of Cancer. Int J Oncol Res 2:018. doi.org/10.23937/2643-4563/1710018 Accepted: October 14, 2019; Published: October 16, 2019 Copyright: © 2019 Segura-Puello HR, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.","PeriodicalId":93572,"journal":{"name":"International journal of oncology research","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Immunotherapy with the Vaccine Based On the Canine Neurotropic Virus (CIMT-54) For the Treatment of Cancer\",\"authors\":\"Puello Hugo Ramiro Segurab, Charry Juan Sebastián Segura, Muñoz-Forero Diana Milena, Mosquera Diana Lorena Nieto, Villamil-Ballesteros Andrea Catalina\",\"doi\":\"10.23937/2643-4563/1710018\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"• Page 1 of 8 • Citation: Segura-Puello HR, Charry JSS, Muñoz-Forero DM, Mosquera DJN, Villamil-Ballesteros AC (2019) Immunotherapy with the Vaccine Based On the Canine Neurotropic Virus (CIMT-54) For the Treatment of Cancer. Int J Oncol Res 2:018. doi.org/10.23937/2643-4563/1710018 Accepted: October 14, 2019; Published: October 16, 2019 Copyright: © 2019 Segura-Puello HR, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.\",\"PeriodicalId\":93572,\"journal\":{\"name\":\"International journal of oncology research\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-10-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International journal of oncology research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.23937/2643-4563/1710018\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of oncology research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23937/2643-4563/1710018","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Immunotherapy with the Vaccine Based On the Canine Neurotropic Virus (CIMT-54) For the Treatment of Cancer
• Page 1 of 8 • Citation: Segura-Puello HR, Charry JSS, Muñoz-Forero DM, Mosquera DJN, Villamil-Ballesteros AC (2019) Immunotherapy with the Vaccine Based On the Canine Neurotropic Virus (CIMT-54) For the Treatment of Cancer. Int J Oncol Res 2:018. doi.org/10.23937/2643-4563/1710018 Accepted: October 14, 2019; Published: October 16, 2019 Copyright: © 2019 Segura-Puello HR, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
